Results 101 to 110 of about 29,473,219 (216)
Successful step-by-step treatment of multiple tumours in neurofibromatosis type 2
Interdisciplinary Neurosurgery, 2019 A clinical study on successful treatment of multifocal brain and spinal cord lesions in neurofibromatosis type 2 in a woman aged 35 years is presented. Magnetic resonance imaging showed bilateral vestibular schwannomas, brain meningiomatosis and multiple
Andrii Sirko +3 more
doaj +1 more source
Periodontal Disease and Salivary Gland Dysfunction in Neurofibromatosis Type 1: A Case–Control Study
Oral Diseases, EarlyView.ABSTRACT Objectives Neurofibromatosis type 1 (NF1) presents with diverse systemic and oral manifestations. The aim of this study was to investigate the periodontal status and salivary alterations in NF1 individuals. Methods A total of 38 individuals with NF1 diagnostic criteria were compared with a control group paired by age and sex.
Eloá Borges Luna +6 more
wiley +1 more source
Macrocephaly in neurofibromatosis type 1: a sign post for optic pathway gliomas? [PDF]
, 2011 Optic pathway gliomas, which occur in 15-20% of paediatric patients with neurofibromatosis type 1, are the most common central nervous system tumour associated with this neurocutaneous disorder.
Barbara Goeggel Simonetti +13 more
core +2 more sources
A large multilobulated cutaneous nodule in infancy
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Hannah Wahida +2 more
wiley +1 more source
Loose Anagen Hair Syndrome: A Scoping Review
Pediatric Dermatology, EarlyView.ABSTRACT Loose anagen hair syndrome (LAHS) is a rare, non‐scarring alopecia that may occur sporadically or follow autosomal dominant inheritance. The objective of this study was to review the etiology, clinical presentation, diagnostic features (including trichoscopy, trichogram, and microscopy), natural history, and treatment outcomes of LAHS.
Romy Shenderey +12 more
wiley +1 more source
AN UNUSUAL CASE: NEUROFIBROMATOSIS TYPE 5
, 2012 Neurofibromatosis is a disease which includes 5 types in its classification. It has been firstly described by Robert Smith in 1849, but its name comes from the first publication in 1882, in which Von Recklinghausen convinced the scientific and medical ...
A. Gunay +22 more
core
American Journal of Medical Genetics Part A, Volume 200, Issue 11, Page 2454-2463, November 2026.ABSTRACT Tuberous sclerosis complex (TSC) is a genetic condition with multisystem neurocutaneous signs, including hamartomas, epilepsy, and neuropsychological difficulties. Although sleep disorders are increasingly recognized in TSC, they remain poorly described in adults.
Kirstin A. Risgaard +6 more
wiley +1 more source
Neurofibromatosis Type 2 – indications and experiences with Bevacizumab
Brain and Spine, 2021 M. Breun +4 more
doaj +1 more source
Assessment of Growth in Cardio‐Facio‐Cutaneous Syndrome
American Journal of Medical Genetics Part A, Volume 200, Issue 11, Page 2443-2453, November 2026.ABSTRACT Cardio‐facio‐cutaneous (CFC) syndrome is a rare, multiple congenital anomaly disorder in which individuals commonly experience faltering growth; however, systematic analysis of growth parameters in this disorder has not been performed. We recruited 69 participants with CFC through CFC International and collected data on assessing height ...
Kari Johnston +6 more
wiley +1 more source